SHREE GANESH REMEDIES
Back to All Ratios
|
SHREE GANESH REMEDIES Last 5 Year PAT Growth History
[Consolidated]
Mar2024 | Mar2020 | Mar2019 | |
---|---|---|---|
PAT Growth(%) | 168.45 | 67.93 | - |
What is the latest PAT Growth ratio of SHREE GANESH REMEDIES ?
Year | PAT Growth |
---|---|
Mar2024 | 168.45 |
Mar2020 | 67.93 |
Mar2019 | - |
How is PAT Growth of SHREE GANESH REMEDIES Trending?
Years | PAT Growth | % Change | |
---|---|---|---|
Mar2024 | 168.45 | 147.98 | |
Mar2020 | 67.93 | 0 | |
Mar2019 | 0 | - |
Other Financial Ratios of SHREE GANESH REMEDIES
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare PAT Growth ratio of peers of SHREE GANESH REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SHREE GANESH REMEDIES | ₹718.4 Cr | -4.3% | -12.6% | -38.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,115.0 Cr | 2.6% | -5.1% | -6.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,735.0 Cr | -0.5% | -10.1% | 21.8% | Stock Analytics | |
CIPLA | ₹126,313.0 Cr | 4.7% | 4.8% | -4.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,592.0 Cr | 0.6% | 5.2% | 8.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,095.0 Cr | 4.3% | -0.7% | -11.4% | Stock Analytics |
SHREE GANESH REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SHREE GANESH REMEDIES | -4.3% |
-12.6% |
-38.4% |
SENSEX | -0% |
-2.4% |
1.2% |
You may also like the below Video Courses